Royalty Pharma plc

Pharmaceutical Preparations·NEW YORK, NY·FY end 12/31·CIK 1802768

Named Executive Officers

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Christopher HiteExecutive Vice President & Vice Chairman	$1.3M	—	—	—	—	$1.3M
Marshall UristM.D., Ph.D. Executive Vice President, Research & Investments	$1.3M	—	—	—	—	$1.3M
Terrance CoyneExecutive Vice President & Chief Financial Officer	$1.3M	—	—	—	—	$1.3M
Pablo LegorretaChief Executive Officer	$937.5K	—	—	—	—	$937.5K

Pablo Legorreta · FY 2025

Salary$937.5K100%

TSR % vs. CEO comp actually paid · 6 fiscal years · Item 402(v) disclosure

TSR

CEO comp

FY20

+13%

$52M

FY21

-19%

$57M

FY22

-18%

$46M

FY23

-39%

$27M

FY24

-43%

$191M

FY25

-15%

$83M

CEO total compMedian employeePay ratio (right axis)